Rare diseases
Investigational molecules
Locations
Avenue D'Ecolys 2 Bus 36, 5020 Namur, Belgium
Labo'Life Belgium focuses on clinical research in Epstein-Barr virus infection and human papillomavirus infection, with trials addressing persistent viral conditions and associated symptom burden.
The sponsor also includes research on infection-related outcomes such as symptom reduction and viral clearance in patients with ongoing viral disease.
Labo'Life Belgium runs clinical trials in conditions such as Papilloma viral infection, Human papilloma virus test, Skin papilloma, Epstein-Barr virus infection reactivation, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on the Effectiveness of 2LPAPI with Interferon Alfa in Clearing Genital HPV Infections in Patients
BelgiumStudy on the Effectiveness of Interferon Alfa, Interleukin-1, and Interleukin-2 in Treating Non-Genital Warts in Patients
BelgiumStudy on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection
BelgiumStudy on the Effectiveness of 2LHERP in Reducing Recurrent Cold Sores in Patients with Frequent Outbreaks
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
